作者: sarah

Anime Tokyo Station: Mobile Suit Gundam GQuuuuuuX -Beginning- Special Exhibition – New Designs Added for Admission Bonus Illustration Cards

TOKYO, July 16, 2025 - (JCN Newswire via SeaPRwire.com) - Anime Tokyo Station is an anime exhibition site focused on Japanese anime content, which has developed a devout fan base around the world. Under the motto, “Make ANIME more interesting, Bringing ANIME far into the future,” it regularly hosts special exhibitions for popular anime and attracts 187,602 visitors (as of June 29, 2025) from both Japan and overseas as a facility that communicates the appeal of Japanese anime to the world.From May 2025, Anime Tokyo Station will be holding a special exhibition of the theatrical pre-release of Mobile Suit Gundam GQuuuuuuX -Beginning-, the latest installment of the Gundam series directed by Kazuya Tsurumaki and the first-ever collaboration between studio khara, known for the Evangelion series, and SUNRISE, the studio behind the Gundam series.It has been decided that two new designs will be added to the illustration cards, which are distributed as an admission bonus. The second design is based on the teaser visual with an impressive back view of Nyaan looking up at MACHU and GQuuuuuuX, and the third design features MACHU looking back, which is the iconic and pop key visual of the TV series. Why not try to complete the entire collection over summer vacation?Come to Anime Tokyo Station and experience the full appeal of Mobile Suit Gundam GQuuuuuuX -Beginning-.New Design Distribution Period- 2nd design: July 5 to July 25- 3rd design: July 26 to August 11For more information on Mobile Suit Gundam GQuuuuuuX -Beginning special exhibition, please visit the link below.https://prtimes.jp/main/html/rd/p/000000008.000017625.htmlVenue Overview- Exhibition Title: Mobile Suit Gundam GQuuuuuuX -Beginning- Special Exhibition- Exhibition Period: May 24, 2025 (Sat) to August 11, 2025 (Mon, Holiday)- Name: Anime Tokyo Station (also known as "Anime Tokyo")- Location: Floors B1 to 2F of Tokyu East 5 (2-25-5 Minami-Ikebukuro, Toshima-ku, Tokyo)*4 minutes on foot from Ikebukuro Station- Hours: 11:00 a.m. to 7:00 p.m. (last admission: 6:45 p.m.)- Closed: Mondays*If Monday falls on a holiday, the venue will be open on Monday and closed on the following day, New Year's holiday period, May be closed on other daysPlease check the venue website before coming.- Admission fee: Free- Website: https://animetokyo.jp/en/Inquiries regarding this press releasePublic Relations Office of "Anime Tokyo Station" (Kyodo PR)Contact person: Miri YasudaE-mail: animetokyo-pr@kyodo-pr.co.jp Press release: https://www.acnnewswire.com/docs/files/20250716.pdf  Copyright 2025 JCN Newswire via SeaPRwire.com.

16 7 月, 2025

大洋环球申转主板上市捉紧商机 迎中国恢复部分日本水产进口机遇

香港,2025年7月15日 - (亚太商讯 via SeaPRwire.com) - 内地早前有条件恢复日本部分地区水产品进口。面对是次政策调整所带来的机遇,香港急冻海产进口商及批发商大洋环球控股有限公司(「大洋环球」或「集团」;股份代号:8476)将深化与中国区客户合作,并采取更积极市场策略,进一步拓展内地业务销售,目标内地收益尽快恢复至禁令实施前水平,即双位数增长。6月29日,中国海关总署发布《关于有条件恢复日本部分地区水产品进口的公告》(《公告》),宣布自当日起恢复部分日本地区水产品进口。《公告》指出,中国将恢复日本除福岛、群马、栃木、茨城、宫城、新舄、长野、埼玉、东京都、千叶等等10个都县以外地区的水产品进口。此次日本水产禁令部分解除,为集团进一步开拓中国市场带来重要契机,将为销售表现带来强大助力。2025财年大洋环球中国业务占集团收益达到11.6%,为香港业务以外的第二大收益来源。于中国对日本水产禁令实施前,中国业务收益增长强劲,2024财年收益按年增长67.3%。大洋环球主席兼行政总裁陈建峰表示:「作为于港澳地区水产品进口领域经验丰富的企业,大洋环球始终将食品安全与质量置于首位,确保进口日本水产均是严格遵循中国海关各项规定,符合高质量与安全标准。未来,大洋环球将继续严格把控进口海产质量,凭借集团在优质急冻水产进口及批发上逾22年的丰富经验,我们可望透过更多元化的水产产品组合,满足周边地区客户需求,积极拓展市场渠道,提升品牌形象,为消费者带来优质安全的进口海产,持续发展创造新增长点。凭借我们于业内的声誉,将有助集团维持与现有供应商及客户的业务关系,以及探索与新供应商及客户的潜在业务机遇。」同时,大洋环球于7月10日收市后正式向联交所申请以转板上市之方式,由GEM转至主板上市及买卖,当中不会涉及发行任何新股份。陈建峰表示:「我们相信转板上市有助提升集团整体形象,进一步加强公众投资者以至客户的认可度,以及增强融资灵活性。随着集团上市地位的提升,冀能把握更多商机,如内地市场以至大湾区相关客户的机遇,我们将继续与业务伙伴携手合作拓展业务,巩固我们作为急冻海鲜进口及批发行业杰出市场参与者的地位,为更多市场和客户提供更多元化、更优质、更安心食用的急冻水产产品及服务,同时为股东创造长期价值。」关于大洋环球控股有限公司(股份代号: 8476)大洋环球控股有限公司是一间业务稳健的香港急冻海鲜进口商及批发商,在急冻海产进口及批发业拥有逾22年经验,供应各式各样的的急冻海鲜产品,涉及超过100个品种,并为超过370名客户(主要为急冻海鲜转售商及急冻海鲜餐饮供应商)服务,知名产品包括加拿大牡丹虾、日本熟帆立贝、Clearwater牌北寄贝、帝王蟹脚、蒲烧鳗鱼、北海道带子、各类刺身虾等,深受消费者喜爱。集团的质量控制程序已获HACCP及ISO 9001认证,乃对致力向客户提供优质产品的认可。 Copyright 2025 亚太商讯 via SeaPRwire.com.

16 7 月, 2025

云顶新耀股价创阶段新高 通用型现货肿瘤治疗性疫苗EVM14″中美双报”再释mRNA平台潜力

香港,2025年7月15日 - (亚太商讯 via SeaPRwire.com) - 今日云顶新耀(01952.HK)股价表现亮眼,盘中最高价触及73.4港元,再创新高。截至收盘,股价报72港元,成交活跃,成交额达3.06亿港元,总市值飙升至235.95亿港元。作为国内率先实现mRNA平台产品转化并在中美多中心推进临床研究的创新药企,云顶新耀在资本市场的热度显著提升。公司多项核心产品进展为其股价上涨提供有力支撑,其中EVM14的最新临床申请获受理成为市场关注的焦点之一。今日稍早,云顶新耀宣布其通用型现货肿瘤治疗性疫苗EVM14注射液的新药临床试验申请(IND)已获得国家药监局药审中心(CDE)正式受理。此前,EVM14已于今年3月获得美国食品药品监督管理局(FDA)批准开展临床试验。本次中国受理,意味着EVM14成为公司首个实现"中美双报"的mRNA创新产品,也标志着云顶新耀全球临床布局再进一步。云顶新耀首席执行官罗永庆表示:"通用型的现货肿瘤治疗性疫苗EVM14成功获得国家药品监督管理局药品审评中心的正式受理,不仅彰显了云顶新耀在mRNA肿瘤治疗领域的技术实力,也体现了监管机构对EVM14科学性与前期研究质量的高度认可。作为公司mRNA平台首个'中美双报'产品,EVM14将为肿瘤患者带来更具突破性的治疗选择。"EVM14是一款靶向5个肿瘤相关抗原的通用型肿瘤治疗性疫苗,拟用于包括鳞状非小细胞肺癌、头颈鳞癌等多种瘤种。其临床前研究显示,EVM14可诱导抗原特异性T细胞应答,在小鼠同源肿瘤模型中有效抑制肿瘤生长,具备诱导免疫记忆、防止复发和转移的潜力。此外,EVM14与抗PD-1/抗CTLA-4免疫检查点抑制剂的联用显示出协同增效作用,支持临床联合治疗探索。2025年6月,云顶新耀已完成首批GMP级临床样品放行,试验将在中国与美国同步推进,合作单位包括美国MD Anderson癌症中心与中国上海市胸科医院等权威机构。作为mRNA平台首个"中美双报"产品,EVM14进展亦凸显了云顶新耀在mRNA技术端到端布局上的优势。公司已构建覆盖抗原设计、序列优化、LNP递送系统及GMP级生产的一体化mRNA平台。此外,云顶新耀专有的"妙算"mRNA序列算法系统(EVER-NEO-1),目前已迭代至第三代,显著提升mRNA表达水平,为平台药物开发提供技术支撑。该平台已得到临床验证,其研发的PTX-COVID19-B在头对头全球II期研究中表现出与辉瑞/BioNTech的Comirnaty疫苗相当的免疫原性与耐受性。在丰富的管线布局方面,云顶新耀的个性化mRNA肿瘤疫苗EVM16亦已于2025年3月完成首例患者给药,初步数据显示可在低剂量下激发特异性T细胞反应,并与抗PD-1抗体联用展现出协同疗效;此外,自体生成CAR-T项目正推进至临床前候选阶段,并在人源化小鼠和非人灵长类动物中展现出良好疗效和安全性。这一系列进展持续释放平台在肿瘤及自身免疫疾病领域的潜力。在此背景下,公司也在持续推动其mRNA平台的全球合作进程。随着核心产品的临床数据逐步披露,云顶新耀在国际BD层面的交流正在加速推进。在6月底举行的"mRNA创新技术平台研发日"活动中,公司表示,已与多家全球Top 20药企建立联系,并收到多个跨国企业表达的初步合作意向。EVM14的"中美双报"则进一步印证了云顶新耀自主mRNA平台具备从抗原筛选、LNP递送体系、CMC工艺开发到产业化生产的全流程能力。该产品的中美临床同步推进,不仅为后续管线的国际开发奠定基础,也为云顶新耀在全球市场开展潜在授权与合作打开了更大的空间。 Copyright 2025 亚太商讯 via SeaPRwire.com.

16 7 月, 2025

耀启新程!康哲药业今日于新加坡交易所主板实现二次上市

深圳,2025年7月15日 - (亚太商讯 via SeaPRwire.com) - 7月15日上午,康哲药业控股有限公司("康哲药业"或"集团")在新加坡交易所正式鸣锣上市(证券简称:CMS,股票代码:8A8)。近百名全球专业机构代表、股东代表、合作伙伴代表以及员工代表,共同见证这一具有战略意义的时刻。这是康哲药业继2010年9月成功登陆香港联交所主板之后,再度以磅礴之势迈向国际资本平台,将吸引专注亚太投资的基金及东南亚本土资本,优化股东结构。同时,也标志着集团深耕新兴市场、推进产业国际化战略的重要里程碑。康哲药业主席兼行政总裁、总裁林刚先生在上市仪式现场致辞:"在新加坡的二次上市,标志着康哲药业实施亚太战略迈出了关键一步,彰显了我们将中国市场优势延伸至整个亚太地区、深化东南亚及中东布局的决心。这不仅助力康哲药业在亚太市场全方位、可持续发展,更提升了公司的国际影响力与竞争力,使我们能够覆盖更广泛的患者群体,为他们提供优质、可负担的用药选择。"新康哲 新崛起三十三年征程,康哲药业通过三次战略转型不断挑战与超越以适配外部生态:从"中国最大CSO"(1992-2010年),到"从CSO向Pharma转换"(2010年起-2018年),再到自2018年起,逐步确立"创新驱动、专科突破、产业国际化"三大核心战略,推动"新康哲"升级迭代,蓄势而发。康哲药业已建立医药产品全生命周期管理体系,覆盖从靶点识别到临床开发,再到产品注册及商业化推广的每一个环节。集团专注FIC、BIC创新产品,精心打造了约 40 款具有差异化优势的创新产品管线,其中 5 款创新药已在中国获批并成功商业化。随着集采影响基本出清,康哲药业已进入由独家药、创新药驱动的高质量、可持续发展新周期。专科方面,集团聚焦心脑血管、消化、眼科、皮肤健康等领域,持续深化产品布局与专家网络。值得一提的是,集团皮肤健康业务"德镁医药",已在细分领域崭露头角,成为行业领军者,并计划于香港联交所主板独立上市。产业国际化出海先锋"研、产、销"全链条协同发力自2022年起,康哲药业启动"产业国际化"战略,将集团在中国市场的优势与资源外溢至新兴市场,并以新加坡为支点,建立涵盖CMS R&D、PharmaGend以及Rxilient在内的本地化集群,实现医药产业"研、产、销"全链条协同发力,放眼全亚太拓展市场深度与广度。商业化体系国际化:Rxilient为药品引进、开发、营销推广平台,由专业、经验丰富的本土化团队运营,以新加坡为总部,业务已拓展至马来西亚、泰国、越南、菲律宾、印尼、中东等14个国家和地区,助力中、美、欧等地合作伙伴的创新药落地新兴市场,同时为当地引入更多优质、可负担的治疗选择。截至目前,Rxilient在东南亚、中东、港澳台地区累计提交了近20款药品和医疗器械的上市申请,覆盖皮肤科、眼科、肿瘤、自身免疫、中枢神经等疾病领域。生产体系国际化:PharmaGend作为国际化CDMO平台,以新加坡为基地,拥有3万平方米生产场地,可生产片剂、胶囊等剂型,并规划拓展注射剂、软膏剂、鼻喷剂等产线,工厂已通过FDA、HSA等国际认证,具备面向全球输出的高标准药品制造能力。庞大人口基数、医保扩容与慢病负担上升等结构性因素,正推动东南亚、中东等新兴市场成为全球医药产业新增长极。康哲药业依托全链条生态体系,正逐步形成中国医药产业出海的新模式,不仅赋能自身产品的新兴市场增量转化,也为全球合作伙伴提供可信的一站式落地机制,为集团注入额外的增长动能。展望未来,康哲药业将持续推动三大核心战略以构建"新康哲"长期价值体系,不断提升医药创新可及性,助力更多患者获益,实现可持续健康发展,并为投资者创造丰厚价值回报。康哲药业免责与前瞻性声明本新闻无意向您做任何产品的推广,非广告用途。本新闻不对任何药品和医疗器械和/或适应症作推荐。若您想了解具体疾病诊疗信息,请遵从医生或其他医疗卫生专业人士的意见或指导。医疗卫生专业人士作出的任何与治疗有关的决定应根据患者的具体情况并遵照药品说明书。由康哲药业编制的此新闻不构成购买或认购任何证券的任何要约或邀请,不形成任何合约或任何其他约束性承诺的依据或加以依赖。本新闻由康哲药业根据其认为可靠之资料及数据编制,但康哲药业并无进行任何说明或保证、明述或暗示,或其他表述,对本新闻内容的真实性、准确性、完整性、公平性及合理性不应加以依赖。本新闻中讨论的若干事宜可能包含涉及康哲药业的市场机会及业务前景的陈述,该等陈述分别或统称为前瞻性声明。该等前瞻性声明并非对未来表现的保证,存在已知及未知的风险、不明朗性及难以预知的假设。康哲药业并不采纳本新闻包含的第三方所做的任何前瞻性声明及预测,康哲药业对该等第三方声明及预测不承担责任。 Copyright 2025 亚太商讯 via SeaPRwire.com.

16 7 月, 2025

AATec Medical 与 Northway Biotech 宣布合作开发用于治疗肺部疾病的 ATL-105 工业化生产工艺

双方建立合作关系,以开发并扩大 ATL-105 的生产规模。ATL-105 是一种新型重组 α1-抗胰蛋白酶。主要适应症为非囊性纤维化支气管扩张症;ATL-105 通过广泛的多模式作用机制,靶向疾病驱动因素。立陶宛维尔纽斯, 2025年7月16日 - (亚太商讯 via SeaPRwire.com) - AATec Medical GmbH(简称“AATec”)是一家致力于开发用于治疗呼吸系统疾病的多产品平台的生物技术公司。 Northway Biotech(简称“Northway Biotech”或“NBT”)是一家全球合同开发与制造组织(CDMO)。两家公司今日宣布建立合作关系,联合开展 AATec 旗下主要候选产品 ATL-105 的生产工艺开发与分析方法开发。ATL-105 是一种专有的重组 α1-抗胰蛋白酶(AAT)吸入式疗法,适用于治疗非囊性纤维化支气管扩张症(NCFB)。AATec Medical 与 Northway Biotech 宣布合作根据协议,Northway Biotech 将利用其在生物制剂生产方面的专业知识,采用毕赤酵母(Pichia pastoris)表达系统开发并扩大 ATL-105 的生产工艺。AATec 联合创始人兼首席执行官、博士 Rüdiger Jankowsky 表示:“通过此次合作,我们正在建立一套稳健且可扩展的 ATL-105 生产工艺,为临床开发和商业化应用奠定一致的质量基础。”他补充道:“ATL-105 代表新一代吸入式生物制剂,在单一分子中结合抗蛋白酶、抗炎和抗感染特性。通过直接递送至肺部,实现快速、精准的作用,并最大程度减少全身暴露。我们相信,ATL-105 有望重新定义如非囊性纤维化支气管扩张症等高未满足医疗需求呼吸疾病的治疗方式。”Northway Biotech 首席执行官兼董事长 Vladas Algirdas Bumelis 教授表示:“我们非常高兴能支持 AATec 向临床试验迈进。AATec 正在推进一项极具前景的治疗方案,旨在应对显著的未满足医疗需求,并拥有一支高效且敬业的团队。凭借我们在微生物系统方面数十年的专业经验,我们有能力高效扩大该项目的生产规模,并在每一个环节确保质量。”Northway Biotech 商务拓展副总裁、博士 André Markmann 补充道:“我们意识到这是一个有潜力显著改善呼吸系统疾病患者护理方式的项目,并希望为其提供支持。吸入式蛋白质疗法正日益受到关注,而 ATL-105 是该领域最具前景的方法之一。”AATec 正在开发 ATL-105,用于治疗非囊性纤维化支气管扩张症(NCFB)——这是一种慢性炎症性呼吸系统疾病,影响着全球数百万患者。该疾病表现为支气管扩张、持续性炎症、频繁的气道感染以及黏液清除功能受损。除了 NCFB 之外,ATL-105 还具有治疗更广泛炎症性和感染性呼吸系统疾病的潜力,例如慢性阻塞性肺疾病(COPD)、急性呼吸窘迫综合征(ARDS)以及其他适应症,充分体现了其抗炎、免疫调节和抗感染的多重作用机制与广泛适用性。关于 AATec MedicalAATec Medical GmbH 是一家生物技术公司,致力于开发以新型重组 α1-抗胰蛋白酶(AAT)为基础的产品平台,用于治疗呼吸道炎症性疾病、气道感染以及罕见病。公司已在多个适应症中成功验证其概念可行性,目前正在为首个候选产品 ATL-105(用于吸入式治疗非囊性纤维化支气管扩张症)开展概念验证临床试验做准备。AATec 由一支在临床研究、生物制药开发和产品产业化方面具有丰富经验的跨学科团队创立。欲了解更多信息,请访问: https://www.aatec-medical.com/ 并关注 AATec 的 LinkedIn页面。关于 Northway BiotechNorthway Biotech 是一家领先的合同开发与制造组织(CDMO),专注于蛋白质类生物制剂和基因疗法,提供全面的一站式生物制药开发与生产服务。公司在细胞株开发、工艺优化以及 cGMP 生产方面拥有深厚专业知识,支持从早期开发到商业化生产的各阶段项目。Northway Biotech 成立于 2004 年,是一家私人控股企业,在立陶宛和美国设有先进的生产设施,能够根据客户的独特需求提供高质量、合规的解决方案。欲了解更多信息,请访问:https://www.northwaybiotech.com   。Northway Biotech 媒体联系:Prof. Vladas Algirdas BumelisCEO and Chairman of the Boardvladas.bumelis@northwaybiotech.comAATec Medical 媒体联系:Dr. Rüdiger Jankowsky, CEOinfo@aatec-medical.com媒体联系:MC ServicesKatja Arnold, Julia von Hummelaatec-medical@mc-services.euPhone: +49 (0)89 2102280来源: Northway Biotech Copyright 2025 亚太商讯 via SeaPRwire.com.

16 7 月, 2025

All Nippon Airways and Hitachi Unveil Japan’s First Airline “Operations Brain” System, Enabling Rapid, Optimal Flight Schedule Revisions During Disruptions

• All Nippon Airways, in partnership with Hitachi, developed a new system that can automatically formulate fast and optimal revision plans for flight schedules to address disruptions from bad weather and other challenges.• By combining All Nippon Airways' operational expertise with Hitachi's planning optimization technology, the partners developed and began operating the system in July.• The system shortens flight schedule revision times by several hours, helping minimize customer impact during irregularities.TOKYO, July 15, 2025 - (JCN Newswire via SeaPRwire.com) - To reduce disruption impacts on customers, All Nippon Airways (ANA) and Hitachi, Ltd. (Hitachi), in collaboration with Hitachi Consulting Co., Ltd. (Hitachi Consulting), launched a system that automatically and rapidly generates optimized flight schedule revisions during disruptions affecting ANA's domestic flight operations. This system was jointly developed by combining ANA's operational expertise with Hitachi's technological capabilities. This is the first time a Japanese airline has implemented such a system.The system dynamically collects and analyzes large amounts of data, including aircraft operation schedules, maintenance plans, crew schedules and various airport conditions, to autonomously generate multiple revised schedule proposals. It intelligently adapts to real-time changes, including modifications to maintenance plans, airport or runway closures and consecutive irregular events across multiple airports. ANA's operations staff can then swiftly review and select the most effective option, significantly reducing decision times and improving operational performance.Previously, ANA relied heavily on the expertise of seasoned operations staff, which created challenges in both human resource development and the time required to formulate optimal schedule revisions that consider complex conditions within a limited timeframe. Therefore, innovation in operation management was needed.Recognizing these challenges, ANA, Hitachi and Hitachi Consulting began developing the system in 20191. Extensive trials confirmed that the system's proposals match the quality of schedules produced by highly experienced operations staff while reducing work time by several hours, especially during large-scale disruptions. For example, in scenarios where typhoons severely disrupted flight operations, veteran ANA staff with more than a decade of experience previously spent entire nights manually adjusting schedules to minimize impact.With the implementation of this new system, we can now:-Reduce the time needed to consider revisions by up to 70%.-Respond flexibly and repeatedly to changes in weather forecasts, such as typhoon paths and speeds.-Relieve the mental stress on operations staff who are pressured to quickly create and decide on schedule revisions.-Improve flight stability by allowing for the rapid comparison of multiple revision options.These benefits are expected to enable faster communication to our customers, which will in turn lead to an enhanced customer experience.Amid the global push for digital technology in the aviation industry, this system boasts exceptional accuracy in two key areas: its versatility to automate solutions for any disruption, from major events to daily issues, and the comprehensiveness to replicate the operational quality ANA has honed in a challenging environment like Japan, with its frequent typhoons and complex flight paths.ANA continues to drive digital transformation by integrating advanced technologies with human expertise, striving to set new global standards for operational excellence. For more information on this system and ANA's flights, please visit the ANA website.Hitachi will plan to expand this system as the Lumada2 solutions. The initiative will extend capabilities to ANA's international operations and other airlines worldwide, supporting critical social infrastructure. Then we aim to improve the productivity of frontline workers and enhance people's well-being. Overview of this system1 March 5, 2020: ANA and Hitachi Engage in Demonstration Experiment to Confirm the Effectiveness of Automatic Recovery Plan Technology for Flight Schedule Revisions.2 Lumada: A collective term for solutions, services, and technologies based on Hitachi's advanced digital technologies for creating value from customers' data accelerating digital innovationAbout ANAFounded in 1952 with just two helicopters, All Nippon Airways (ANA) has grown to become the largest airline in Japan. Today, ANA HOLDINGS Inc. (ANA HD) is recognized as one of the World's Most Admired companies by Fortune.ANAHD was established in 2013 as the largest airline group holding company in Japan, comprising 71 companies. It offers three distinct airline brands: ANA, Peach, the leading LCC in Japan, and AirJapan, launched in 2024 for international routes covering Asia.ANA's legacy of superior service has earned SKYTRAX's 5-Star rating every year since 2013, making it the only Japanese airline to win this prestigious designation for 12 consecutive years.ANA is also a four-time recipient of the ATW Airline of the Year award, recognized for excellence in aviation.ANAHD has been selected as a member of the Dow Jones Sustainability World Index list for eight consecutive years and the Dow Jones Sustainability Asia Pacific Index list for nine consecutive years.For more information about ANA and ANA HD, please visit: https://www.ana.co.jp/group/en/About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT(Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors - Digital Systems & Services, Energy, Mobility, and Connective Industries - and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.comMedia ContactANA Corporate Communications+81-3-6735-1111publicrelations@ana.co.jpBusiness ContactHitachi, Ltd.Connective IndustriesInquiry Form : Industry : HitachiConnective Industries Division, Hitachi, Ltd.+81- 80-6859-4302 (Ebisu)+81- 70-4349-6137 (Iijima) Copyright 2025 JCN Newswire via SeaPRwire.com.

16 7 月, 2025

恺英网络获得4号及9号牌照:持续拓宽业务边界 全球化布局更进一步

导语:加速游戏虚拟资产管理业务进程和全球化布局。香港,2025年7月14日 - (亚太商讯 via SeaPRwire.com) - 日前,恺英网络旗下全资子公司Spruce Technology HK Limited正式获香港证券及期货事务监察委员会(SFC)颁发第4类(就证券提供意见)及第9类(提供资产管理)牌照。上一个在内地引发广泛关注的类似事件,是去年12月字节跳动联合创始人张一鸣通过旗下"Cool River Venture HK Limited"斩获香港9号牌照。从地域来看,香港正加速推动成为全球Web3.0中心。对正处于游戏业务全球化加速期,且积极布局元宇宙、Web3.0等前沿赛道的恺英网络而言,这两个牌照将成为其生态升级的核心支点:公司不仅能吸引更多国际合作伙伴共同开发AI驱动的游戏开发工具与PUGC平台,更能合规开展游戏虚拟资产生成、交易及资产管理业务,从而打通"创意-资产-金融"闭环,构建可信赖的全球化数字经济生态。牌照不是终点 打造更具想象力的"游戏虚拟资产管理者"恺英网络长期以来一直积极探索Web3.0、元宇宙等新兴领域的前沿技术与资本运作深度融合。早在2023年,恺英网络就曾透露,其从技术框架上可支持产品接入Web3.0,并将持续关注Web3.0技术的发展。此外,恺英网络还早早搭建了数字资产平台「拾元立方」,致力于通过区块链技术并结合Web3.0、元宇宙和人工智能,汇集多方创作者和游戏品牌方,构建数字艺术品营销体系,建立数字品牌形象,打造丰富多元的元宇宙内容生态。截至目前,「拾元立方」已发布了多款原创IP和品牌联动数字艺术品,以"数字资产与实体经济"相结合的发售方式,促进数字经济与实体经济深度融合。2024年巴黎奥运会首日,恺英网络公司吉祥物"K小皇"奥运系列数字资产就在「拾元立方」独家限量首发,定制数字资产互动小游戏「奥运"皇"家助威团」同步上线。用户可以通过参与游戏获得专属独特的数字资产奖励,数字资产将绑定平台权益,为数字资产的普及和应用开辟了新的道路。根据市场数据,「拾元立方」现已拥有实名注册用户近20万,未来能够帮助出海厂商实现游戏数字资产海外发行,形成"国内合规发行+海外多链流通"的双轨模式,为游戏资产全球化提供从技术底层到交易场景的一站式解决方案。在恺英网络之前,海外代表性游戏公司已通过获取金融牌照布局虚拟资产管理业务,验证了这一路径的可行性:香港 Web3 头部企业 Animoca Brands 通过获取相关合规资质,构建了覆盖元宇宙资产发行、交易的全链条管理体系;由动视暴雪前核心团队创立的 Mythical Games,亦凭借合规框架下的"隐形化区块链技术",在《Blankos Block Party》等代表作中实现玩家资产的安全持有与交易,成为区块链游戏领域通过牌照合规打通虚拟资产价值闭环的标杆。随着4号及9号牌照的获得,恺英网络或将进一步拓宽在虚拟社交、区块链游戏等相关领域的业务边界,用游戏行为产生资产,用金融牌照盘活资产,闭环生态形成,从而成为一个"更具想象力的恺英"。基于已有的海外布局经验 构建开放、可信的全球化PUGC平台从另一个角度来看,在本次获得香港SFC第4类及第9类牌照前,恺英网络的全球化战略就已显成效。从产品端来看,积极把握海外市场机遇,积极布局全球化发行,放眼全球市场,与众多海外渠道建立了深入合作关系,在海外市场拓展方面的成绩颇为亮眼。据了解,2025年新游《MU Immortal》《派对不兽控》等游戏均在上线伊始即登顶海外地区游戏榜单,成长实力不容小觑。多款新品的相继推出,有望进一步完善恺英网络的产品矩阵并逐渐形成差异化竞争力,从而进一步扩大市场份额,推动用户规模实现阶梯式增长。反映在业绩表现上,2024年恺英网络海外营收3.75亿元,同比增长多达221.48%。就在6月底,恺英网络向市场推出了一款专为游戏行业打造的AI全流程开发平台"SOON"。该平台凭借对多模态大模型能力的深度整合,实现了从美术资产生成到代码部署全流程的自动化操作,极大地缩短了传统游戏开发周期,充分赋能游戏行业向全自动AI转型。结合这家公司在游戏出海和自研AI开发平台等一系列动作,可以猜测,公司将在海外或也会打造AI全流程游戏开发工具和PUGC玩家用户平台,海外用户平台面向玩家群体,提供多玩法、多创意的AI游戏产品。在SFC两个金融牌照的加持下,平台提供虚拟经济系统,海外开发者可以通过平台系统或平台上的游戏自己生成游戏代币,帮助游戏开发者完善经济系统。从这个角度来看,基于过去一段时间在海外游戏运营发行积累的经验,以及海外市场对Web3.0创新模式更加深刻的理解,恺英网络有望构建一个真正开放、可信的全球化PUGC平台,赋能数字内容与经济系统的创新。 Copyright 2025 亚太商讯 via SeaPRwire.com.

15 7 月, 2025

Fujitsu’s AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum

KAWASAKI, Japan, July 14, 2025 - (JCN Newswire via SeaPRwire.com) - Fujitsu Limited today announced that one of its Fujitsu Uvance solutions that optimizes customers' global supply chains using specialized AI agents has been selected by the World Economic Forum's (WEF) AI Governance Alliance as one of 18 global advanced AI solutions that are transforming business. An independent, cross-industry group of AI leaders worldwide participated in selecting the solutions for the MINDS Programme from hundreds of applications. Applications were anonymized, and the final selection was based on cases that were implemented in actual settings and that have already achieved concrete results. The MINDS Programme (Meaningful, Intelligent, Novel, Deployable Solutions) was launched by WEF to spotlight AI applications already delivering real impact across critical sectors like healthcare, energy and financial services.Developed on the "Fujitsu Data Intelligence PaaS (1)" all-in-one operation platform offered under the Fujitsu Uvance business model to solve societal issue, the solution transforms inventory management and ordering operations in the supply chain and supports advanced management decision-making. The "Fujitsu Kozuchi AutoML" AI service, which can rapidly generate high-precision machine learning models, creates dozens of demand forecasting models in minutes from data automatically gathered and ordered using a knowledge graph. The solution employs multiple AI agents specialized for tasks such as procurement, inventory, production, and sales. Based on real-time alerts for inventory shortages or excess inventory, each AI agent develops countermeasures such as changing suppliers or allocating inventory. From the proposed countermeasures, the orchestrator agent selects the best option considering the balance of cost, lead time, and risk, and the evaluator agent assesses its validity, enabling users to quickly take optimal action based on proposals made by AI.A simulation carried out using data from an imagined major company with approximately US$10 billion in annual sales, showed the solution reducing annual inventory management costs by approximately US$15 million and cutting unnecessary inventory stock by approximately US$20 million, in addition to reducing work hours by more than 50%. The solution was also able to carry out an operating profit impact assessment following a simulated natural disaster within 3 hours of its occurrence. Fujitsu provides this solution to manufacturing customers facing inventory management challenges, supporting supply chain efficiency and resilience enhancement. Moving forward, Fujitsu will continue to assist its customers in making optimal decisions to swiftly respond to unforeseen events such as geopolitical risks, natural disasters, and market fluctuations. Under Fujitsu Uvance, Fujitsu will leverage Decision Intelligence utilizing data and AI to strengthen sustainability in the face of supply chain uncertainty, advancing both corporate value creation and social contribution.(1) Fujitsu Data Intelligence PaaS : Fujitsu's platform service that securely integrates and stores structured and unstructured data dispersed inside and outside the enterprise, and builds a high-speed data analysis infrastructure while ensuring governance. By combining advanced AI technology, it is possible to quickly analyze integrated and stored data and derive information necessary for decision-making in real time.About FujitsuFujitsu’s purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers around the globe, our 113,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: AI, Computing, Networks, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$23 billion) for the fiscal year ended March 31, 2025 and remains the top digital services company in Japan by market share. Find out more: global.fujitsu.Press ContactsFujitsu LimitedPublic and Investor Relations DivisionInquiries Copyright 2025 JCN Newswire via SeaPRwire.com.

15 7 月, 2025

“URECE” (Dotinurad) Launched in China as a treatment for Gout

TOKYO, July 14, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has launched “URECE®” (brand name in China: “Youlesi®”, generic name: dotinurad) in China as a treatment for Gout. URECE was approved by the National Medical Products Administration in China as a treatment for gout patients with hyperuricemia in December 2024.URECE is a new therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. It suppresses uric acid reabsorption and lowers blood uric acid levels by selectively inhibiting the urate transporter (URAT1) related to reabsorption of uric acid in the kidney.Eisai concluded a license agreement with FUJI YAKUHIN for China and five ASEAN member states: Indonesia, Malaysia, Myanmar, the Philippines, and Thailand, granting exclusive development and distribution rights in these countries. This approval in China is based on the results of a multicenter, active controlled, double-blind, parallel-group, randomized, Phase 3 study of 451 gout patients conducted in China by Eisai.1 The results of this study showed that the proportion of subjects with serum uric acid levels of 6.0mg/dL or less at 24 weeks, which was the primary endpoint, was 73.6% [95% confidence interval (CI): 67.8,79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the comparator febuxostat group, confirming the statistical superiority of dotinurad 4 mg over febuxostat 40 mg (difference of proportion 35.87% [95%CI: 27.36, 44.37, p less than 0.001]) (see section 3. About the Phase 3 Clinical Trial”). Eisai has obtained approval for dotinurad in China, Thailand and the Philippines.Gout can develop at any age, is more common in men than women, and during an acute attack, can cause severe joint pain, swelling, redness, and inflammation. The pain gradually improves over a few days, but can sometimes last for weeks. If left untreated, the joint tissue may become damaged and deformed, leading to restrictions in daily activities and a decrease in quality of life.2The prevalence of gout is increasing, and it is estimated that there are currently about 23 million patients with gout in China.3 It is expected that the number of patients will further increase in the near future due tochanges in lifestyle and dietary preferences in accordance with socioeconomic development. Eisai is committed to providing URECE to more patients with gout in China as a new treatment option, and will contribute to improving the quality of life (QOL) of patients.“Youlesi®”Product OutlineChinese Trade name: “Youlesi” (URECE)Chinese generic name: Duo ti nuo lei pian (Dotinurad Tablets)Indication for use: It is indicated for gout patients with hyperuricemia.Dosage and administration: For oral use, the usual adult initial dosage is 1 mg of dotinurad once daily. The dose level should then be gradually increased as needed by checking blood uric acid levels. The usual maintenance dosage is 2mg once daily and may be adjusted according to the patient’s condition, but up to 4 mg once dailyAbout “URECE®” (Dotinurad)URECE is a therapeutic medicine for gout and hyperuricemia discovered by FUJI YAKUHIN. URECE selectively inhibits URAT1, one of the uric acid transporters, thus preventing reabsorption of uric acid by the kidneys and promoting uric acid excretion in the urine. In addition, URECE has a small effect on other transporters affecting uric acid secretion, so it reduces serum uric acid levels at lower doses. URECE is expected to have a low risk of side effects and drug interactions. In Japan, FUJI YAKUHIN obtained manufacturing and marketing approval for URECE in January 2020 and launched it in May 2020.Eisai concluded a license agreement with FUJI YAKUHIN for China and five ASEAN member states: Indonesia, Malaysia, Myanmar, the Philippines, and Thailand, granting exclusive development and distribution rights in these countries. URECE was approved in Thailand for gout and hyperuricemia in Thailand in September, 2024 and in the Philippines in February, 2025.About the Phase 3 Clinical Trial (Study FYU-981-J086-301)1This was a multicenter, active-controlled, double-blind, parallel-group, randomized, Phase 3 study conducted to confirm the superiority of dotinurad 4 mg over febuxostat 40 mg as the primary endpoint, assess safety, and confirm the noninferiority of dotinurad 2 mg to febuxostat 40 mg as the secondary endpoint in Chinese patients with gout. Patients with gout and serum uric acid (SUA) levels exceeding 7.0 mg/dL were randomly assigned to either the dotinurad group or the febuxostat group in a 1:1 ratio, investigational product treatment for 24 weeks (the dotinurad group received 1 mg/day for 4 weeks, 2 mg/day for 8 weeks, and 4 mg/day for 12 weeks, while the febuxostat group received 20 mg/day for 4 weeks and 40 mg/day for 20 weeks). The primary endpoint was the proportion of patients with SUA less than or equal to 6.0 mg/dL at 24 weeks, and the secondary endpoint was the proportion of patients with SUA less than or equal to 6.0 mg/dL at 12 weeks.Of the total 451 patients, 225 were assigned to the dotinurad group and 226 to the febuxostat group. Of these, 441 patients (220 in the dotinurad group and 221 in the febuxostat group) were included in the Full Analysis Set (FAS). For the primary endpoint, the proportion of patients with SUA less than or equal to 6.0 mg/dL at 24 weeks was 73.6% [95% confidence interval (CI): 67.8, 79.5] in the dotinurad group and 38.1% [95% CI: 31.6, 44.5] in the febuxostat group, confirming the statistical superiority of dotinurad 4 mg over febuxostat 40 mg (difference of proportion 35.87% [95% CI: 27.36, 44.37, p less than 0.001]).For the secondary endpoint, the proportion of patients with SUA less than or equal to 6.0 mg/dL at 12 weeks was 55.5% in the dotinurad group and 50.5% in the febuxostat group, confirming the statistical non-inferiority of dotinurad 2 mg to febuxostat 40mg (difference of proportion 5.24% [95% CI: -3.69, 14.17]).The most common adverse events were gouty arthritis, COVID-19, and liver function abnormality in the dotinurad group, and gouty arthritis, COVID-19, and increased alanine aminotransferase (ALT) in the febuxostat group. No new safety concerns with dotinurad were observed.References1. Sun J, Wang Y, Zhang X, et al. POS0255 A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PHASE 3 STUDYCOMPARING EFFICACY OF DOTINURAD AND FEBUXOSTAT FOR THE TREATMENT OF GOUT IN CHINESESUBJECTS. Annals of the Rheumatic Diseases 2024;83:407-408.2. Huang, J., Ma, Z.F., Tian, Y. et al. Epidemiology and Prevalence of Gout in Mainland China: an Updated Systematic Review and Meta-Analysis. SN Compr. Clin. Med. 2, 1593–1606 (2020).3. Estimated data calculated from reference 2 and United Nations World Population Estimates - World Population Prospects, URL: https://population.un.org/wpp/Media Inquiries:Eisai Co., Ltd.Public Relations DepartmentTEL: +81-(0)3-3817-5120 Copyright 2025 JCN Newswire via SeaPRwire.com.

14 7 月, 2025

云工场科技:锚定第二增长曲线 铸就边缘智能新时代

香港,2025年7月11日 - (亚太商讯 via SeaPRwire.com) - 在当今,确定性越来越少、不确定性成为常态的社会中,企业如何展开第二增长曲线已成为企业不得不面对的挑战。云工场科技以"边缘云 + AI 服务平台"为组合拳,作为第二增长曲线推向市场。生成式AI市场爆发,AI基础设施成为竞争新高地生成式人工智能正加速在向各行业渗透,全球 AI 能力平台市场成指数型扩张,根据 Fortune Business Insights 发布的研究报告,全球生成式AI市场规模已从2023年的438.7亿美元增长至2024年的671.8亿美元,预计到 2032 年将达 9676.65 亿美元,年复合增长率(CAGR)高达 39.6%。增长的动力主要来源于AI技术的成熟度,云计算的不断渗透及企业对自动化需求的加速。多家产业研究机构指出,AI 应用重心已从模型训练转向场景部署。具备全国节点布局+本地化算力调度+一站式模型服务平台能力的服务商,将在未来3-5年内获得超额收益。云工场科技正是在此趋势下,系统性的构建第二增长曲线, - - - 基于边缘云、异构算力调度和模型服务平台,成为国际领先的边缘计算和 AI 服务的提供商。云工场科技从全国边缘节点起步,构建"云-边-端"协同平台云工场科技自 2022 年就开始围绕边缘计算进行战略布局,依托其全国 2000+ 区县的边缘节点资源,打通资源、调度、服务三个层级,构建了灵境云一站式服务平台体系,打造"云 - 边 - 端"协同的AI基础设施。云工场科技"云 - 边 - 端"协同的AI基础设施服务体系,更像是一个按需使用的"六边形战士",IaaS层构建分布式边缘云网络,PaaS层提供算力调度平台与 AIoT 平台协同,到 MaaS 层多元化能力应用、SaaS 层行业场景深度整合的全栈技术体系,促进 AI 应用场景技术创新,助力大模型行业应用加速落地。模式上,"边缘云 + AI 服务平台"模式创新发展,推动、算力、平台、模型服务协同发展。技术侧,"云 - 边 -端"全场景 AI 训练推理协同框架,融合云端的异构算力支持模型训练,一键部署到边缘, 凭借云工场科技 2000+ 区县的边缘节点资源,减少数据回传,极大的降低推理成本。应用侧,IaaS、PaaS 、MaaS、SaaS层产品及服务能力下沉到场景推进人工智能技术下的应用落地。灵境云平台体系支持算力租赁、模型微调、模型私有部署、异构调度等多重能力,适用政企、金融、教育、交通、工业等场景。另外,其模型接入到推理部署的全链路能力已实现规模化交付。据云工场科技方面透露,灵境云平台体系已完多项目的落地及重复采购,行业客户对其"部署周期短、定制能力强、响应延迟低"给予高度评价。参与国家级平台建设,助力大模型服务标准化与规模化交付云工场科技的商业化的验证已取得实质性进展,作为工信部2023年"面向人工智能大模型工程化技术及应用的产业公共服务平台"。建设的重要承接单位之一,该平台聚焦于提升全国大模型算力资源的统筹调度与服务能力,涵盖底层异构算力对接、国产主力模型接入、行业数据集标准化管理三大模块。截至目前,平台已成功上线,并集成覆盖国内主流大模型 30+ 个、完成超 500+ 企业开发者接入申请。云工场科技不仅提供底层算力调度系统,也参与了平台使用场景与政企数据接入标准的建设,在算力编排效率与安全合规方面具有突出贡献。云工场科技在大模型公共服务平台的建设经验,已经在其他区域成功复制,验证其商业模式可行性。云工场科技已参与武汉某算力平台的联合建设,依托于灵境云底座,提供关于算力异构算力的部署、调度、算力券的发放。助力国产芯片适配能力的输出,打造企业可灵活部署、安全、可靠、合规的 AI 服务体系。在 AIoT 场景下,灵境云平台也展现出高度的场景适配能力。以"AI+交通"的道路巡查为代表,已在四川绵阳、遵义、南京、温州等多个城市实现规模化部署。 在道路巡查过程中实时采集图像数据,并依托本地边缘节点完成病害识别与处理判断,无需将数据回传中心服务器即可完成智能分析与响应,相比传统中心式架构,该模式降低了数据传输成本与响应延迟,更适配对数据隐私与本地部署有强需求的城市治理场景。同时,云工场科技也正在和无锡、山东、北京、湖南等地的相关政府、行业龙头企业及高校达成战略合作,计划共同建设AI 端到端场景化应用,以支撑其当地产业、城市智能治理与基础设施的升级。这些城市和场景的落地,标志着灵境云平台的商业化复制能力正得到持续验证与拓展。从轻资产 IDC 到边缘云第一股云工场科技以轻资产模式切入 IDC 行业,聚焦数据中心和云计算领域的边缘计算板块,在2024年香港主板敲钟上市,成为"边缘云第一股"。一方面云工场科技通过行业经验的沉淀,为行业提供开箱即用的算力调度平台,另一方面,通过模型开发,数据管理与 AI 场景化能力的落地,结合算力下沉与算网融合,为各行业客户提供高实时、快响应的边缘 AI 应用解决方案,云工场科技的创始人兼董事长孙涛表示:站在 AI 基础设施竞争的新起点上,我们正以可验证的第二增长曲线,打开从"资源运营'走向'能力输出"的长期增长空间,通过灵境云平台构建可复制、可交付的 AI 服务能力。未来,云工场科技将持续打磨更适配场景需求、更普惠易用的 AI 基础设施及产品服务,通过"边缘云 + AI 服务平台"的创新模式,让 AI 真正深入到各行各业前线,实现从技术普惠到价值普惠的跨越,最终推动千行百业的数字化转型与智能化升级。 Copyright 2025 亚太商讯 via SeaPRwire.com.

12 7 月, 2025

第十届【华富卓越投资者关系大奖】颁奖典礼圆满举行

香港,2025年7月10日 - (亚太商讯 via SeaPRwire.com) -「华富卓越投资者关系大奖2024」(简称「大奖」)于2025年7月9日假香港文华东方酒店(Mandarin Oriental Hong Kong) 顺利举行,表扬在复杂的金融和投资环境下,有效实践最佳守则的投资者关系及可持续发展团队。由华富投资者关系主办的「华富卓越投资者关系大奖」迎来十周年,多年来嘉许众多表现优异的上市公司,大会欣喜见证各界不断进步,力求精益求精。华富建业金融集团财务总监麦美娟女士(左七)及首席投资总监颜志军博(右八)与颁奖嘉宾及得奖公司代表合照。十周年里程碑 树立典范巩固市场信心上市公司披露资料的公平性及透明度,是公众作出投资决定的重要考虑因素,除了可提升大众对企业的认知,亦能推动金融市场健康发展。「华富卓越投资者关系大奖」过去十年推动业界共同进步,以加强投资者及上市公司之间的沟通和信任,至今已嘉许众多上市公司,认受性亦持续提升,华富投资者关系对此深表荣幸。受整体经济环境影响,市场气氛欠佳,对上市公司构成不小的挑战,犹幸本届「大奖」仍获上市公司热烈支持,共有10家公司获奖,相信凭借业界努力不懈,定能巩固投资者信心。嘉许可持续发展成就 迎接挑战与机遇为肯定机构在实践可持续发展目标上的表现及贡献,「华富投资者关系大奖以「可持续发展类别」表彰在环境、社会及管治(ESG)方面整体表现出色的企业。本年设立「可持续发展类别 - 年度最佳报告」特别大奖,表扬企业通过发布ESG报告,来展示其在可持续发展方面的表现和承诺,并由安踏体育用品有限公司勇夺殊荣。ESG议题的重要性与日俱增,大会今年特意邀请本识顾问Alaya Consulting Limited带来专题演讲,由创始人及GRI授权培训师黄有杰先生,以「探索ESG披露趋势: 香港上市公司的挑战与机遇」为题,让业界在迈向可持续发展的道路上掌握最新ESG情况。掌握市场动态 创造长期价值华富建业资产管理有限公司行政总裁邓思杰先生致开幕辞表示:「十周年是一个重要的里程碑,我们衷心感谢过去十年业界的全力支持。过去十年,我们见证了诸多变革,例如不断演进的法规以及投资者对透明度日益增长的期望。然而,投资者关系的核心原则始终不变,依然是与市场建立信任、促进对话并创造长期价值。多年来,获奖的企业均赢得了投资者的认可,秉持专业的投资者关系,实至名归。」华富建业国际金融有限公司首席投资总监颜志军博士致辞时表示:「展望未来,随着人工智能(AI)的快速发展,投资者关系专才需要比以往更迅速掌握市场动态。人工智能能简化流程、提供更精准的洞察,并预测市场趋势,若能加以善用,定能提高投资者关系的工作标准,与市场达致更高效的双向沟通。」颁奖典礼获各界朋友和传媒支持华富投资者关系荣幸邀请到香港证券及投资学会董事局成员徐联安博士、香港市务学会荣誉主席陈裕光博士,以及本识顾问创始人及GRI授权培训师黄有杰先生担任颁奖嘉宾,共证盛事。是次颁奖典礼获得商界朋友及两地传媒广泛支持,﹙排名不分先后﹚包括香港上市公司商会、香港独立非执行董事协会、香港证券及投资学会、《汇通财经》及《泡财经》。【华富卓越投资者关系大奖2024】 得奖企业(按英文名称字母排序)股票编号公司香港指数成份股 (恒生指数) 类别0006电能实业有限公司2382舜宇光学科技(集团)有限公司 主板类别0081中国海外宏洋集团有限公司0242信德集团有限公司6811太兴集团控股有限公司1489GC Construction Holdings Limited 可持续发展类别铂金奖2020安踏体育用品有限公司金奖NA欧绿保综合环保(香港)有限公司3613北京同仁堂国药有限公司银奖1229南南资源实业有限公司年度最佳报告2020安踏体育用品有限公司【华富卓越投资者关系大奖2024】网站: https://eventedm.quamhkir.com/QIRA2024-25/查询及联络:华富投资者关系活动推广/传媒联络:卢秋玲 (Mandy Lo) T: 2217-2753 Email:mandy.lo@quamgroup.com 陈碧虹 (Charlie Chan) T: 2217-2504 Email:charlie.chan@quamgroup.com Copyright 2025 亚太商讯 via SeaPRwire.com.

11 7 月, 2025

港交所单日“五连发” 联控体系贡献近半

香港,2025年7月10日 - (亚太商讯 via SeaPRwire.com) - 今年以来,港交所上市热潮提速,"科企专线"和A股来港上市"绿色通道"的开通协同发力,驱动IPO市场显著升温。7月9日,港交所迎来年内最拥挤上市日,五家新股携一只ETF敲锣IPO。其中,蓝思科技(6613.HK)和峰岹科技(1304.HK)均为联想控股(3396.HK)体系各基金平台所投资的企业。其中,蓝思科技是一家以科技创新为核心、智能智造为驱动,业内领先的智能终端全产业链一站式精密制造解决方案提供商。作为它的基石投资人之一,联控体系弘毅投资旗下金涌投资通过子公司出资600万美元认购其股份。公司自1993年成立于深圳,2015年在深交所创业板上市。在湖南、广东、江苏和越南等地区和国家拥有9大研发生产基地,自建办公、厂房建筑面积788万平米,提供就业岗位超13万个,总资产超 800 亿元。蓝思科技于今年3月31日向港交所递交招股书,到6月20日迎来上市聆讯,再到昨日正式挂牌上市,用时仅100天时间。蓝思科技本次港股IPO获国际顶级机构高度认可,香港公开发售获462.76倍认购,国际发售录得16.68倍认购,募资达47.68亿港元。蓝思科技此次港股上市集资,将重点投向核心技术研发、全球产能扩张及新兴赛道布局,为投资者创造多元化价值增长点:持续加码AR光学、智能感知、新材料等领域研发投入,深化消费电子与智能汽车的协同效应,推动"一块玻璃"从手机、平板向汽车座舱、AR眼镜、人形机器人等场景延伸。弘毅投资及旗下金涌投资持续看好中国科技企业发展。此次基石投资秉持金融助力实体行业发展初心,以金融活水滋养新质生产力高速发展。弘毅投资及金涌投资表示,未来将继续做好耐心资本,持续助力蓝思科技打造国际领先的智能智造企业。联控体系另一家基金公司君联资本所投企业峰岹科技,是一家芯片设计公司,专注于BLDC电机驱动控制芯片的设计与研发,并在BLDC电机主控及驱动芯片行业建立强大的市场地位。根据弗若斯特沙利文的资料:公司是中国首家专注于BLDC电机驱动控制芯片设计的厂商;及截至2023年12月31日,公司在中国BLDC电机主控及驱动芯片市场的份额达到4.8%(按收入计),排名第六,且峰岹科技为该市场前十大企业中唯一的中国企业。公司本次香港公开发售获138.26倍认购,国际配售认购倍数为8.61倍,为上市当日定价最高的企业。公开资料显示,君联资本于2019年底投资峰岹科技,投资后在公司产业链上下游资源引荐等方面给予了支持和帮助。君联资本曾表示:"从成立之初,君联资本就开始了芯片、半导体领域的投资,并在后来确立为主要的投资方向之一。峰岹科技是君联资本在这一领域投资布局的高性能BLDC电机驱动控制专用芯片的国产替代企业,是我国唯一一家实现了电机驱动控制芯片内核自主研发的公司。峰岹科技是行业中少有的既有全球领先BLDC控制算法/主控芯片能力,又有电机丰富设计经验的企业。集成电路产业是信息产业的基础和支柱,而集成电路设计是集成电路产业链的关键环节之一,在我国大力扶持集成电路产业发展的大背景下,电机驱动控制芯片发展前景广阔。我们看好峰岹科技上市后的未来发展。"香港特区政府财政司司长陈茂波日前发布的网志表示,上半年香港市场共完成了42宗IPO项目,募资总额超过1,070亿港元,较2024年全年规模增长约22%,暂列全球第一。此外,申请赴港IPO的企业数量也在快速增加,至今已收到约200起上市申请,较年初数据倍增。根据港交所公开信息显示,7月1日至7月9日短短几日,递表的企业已达20家,可见港股IPO市场火热。本次蓝思科技和峰岹科技在港股市场的成功上市,不仅标志着两家企业迈入发展新阶段,也清晰反映了联想控股在科技领域前瞻性投资布局的持续收获。随着港股IPO市场展现出强劲势头,资本市场的活跃为待上市企业提供了更佳的估值环境和流动性通道。联想控股体系所积淀的科技类优质资产有望加速对接资本市场,释放内在价值。消息来源:投资界、弘毅投资、君联资本等微信公众号 Copyright 2025 亚太商讯 via SeaPRwire.com.

11 7 月, 2025

All-New MAZDA CX-5 Debuts in Europe

HIROSHIMA, Japan, July 10, 2025 - (JCN Newswire via SeaPRwire.com) - Mazda Motor Corporation has announced that Mazda Motor Europe, the company responsible for Mazda's European operations, unveiled the all-new MAZDA CX-5 crossover SUV on July 10, 2025, at the local time.All-new MAZDA CX-5 Debut (European specification model)The CX-5 was introduced in 2012 as the first model to fully adopt Mazda's design theme, "KODO - Soul of Motion" that imbues soul into the car, and SKYACTIV TECHNOLOGY, which delivers outstanding driving performance and environmental performance. Since then, it has grown to become Mazda's best-selling model*1, with sales in more than 100 countries and regions around the world and the cumulative global sales exceeding 4.5 million units*2. The CX-5 has been chosen by many customers for its sporty and urban design, "Jinba-Ittai" driving experience that allows the driver to control the car at one’s will, and the carefully crafted interior.The development concept for the new CX-5, now in its third generation, is “New Generation Emotional Daily Comfort” to make it even more loved by customers. While inheriting and evolving the Soul of Motion design and the Jinba-Ittai driving performance, the new CX-5 offers joy and excitement when you look at, touch, and ride in the car. In addition, by improving the interior space and usability, ride comfort, and quietness, it supports a comfortable drive in a variety of situations, such as shopping, leisure, and transporting children. In addition, the all-new Human Machine Interface*3, the enhanced connectivity with the newly added apps, and the evolved Advanced Driver-Assistance Systems (ADAS) help expand the experience that matches in this day and era. We aimed to create a car that allows all occupants to enjoy driving in safety, security, and comfort.The new CX-5 will arrive showrooms in Europe at the end of 2025; and in other markets during 2026.All-new MAZDA CX-5 (European specification model)Mazda will continue to pursue the "Joy of Driving" under its core value of Radially Human, and aim to deliver the "Joy of Living" by creating moving mobility experiences in the daily lives of its customers.*1 The best selling model in Mazda’s product lineup since 2018.*2 The cumulative sales volume is based on Mazda’s data.*3 It is a generic term for a method of exchanging information between humans and machines, as well as the devices and software used for this purpose.Primary specifications (European specification model)Overall dimensions (length/width/height)4,690mm/1,860mm/1,695mmEnginee-SKYACTIV G 2.5 (with Mazda M Hybrid)TransmissionSKYACTIV-DRIVE (6-speed automatic)Suspension (front/rear)MacPherson strut/multi-linkSeating capacity5The single type of the 2.5-liter direct-injection petrol engine is available for the new CX-5. Performance values vary by market.Mazda's mild hybrid system, Mazda M Hybrid, which contributes to improved fuel economy and smooth driving, will come with the 2.5-liter petrol engine of the new CX-5 for Europe, Japan, and other markets.SKYACTIV-Z," which is under development to achieve ideal combustion, will be introduced by the end of 2027 in combination with Mazda's unique new hybrid system.All-New MAZDA CX-5 FilmsUnveiling the All-New MAZDA CX-5The All-New MAZDA CX-5 - Comfortable Interior Space “ANYONE, ANYWHERE, ANYTIME.”  Copyright 2025 JCN Newswire via SeaPRwire.com.

11 7 月, 2025

Sharp Signs Official Partnership with Tottenham Hotspur FC Pre-season Tour 2025 with Its AQUOS Brand

Osaka, Japan, July 10, 2025 - (JCN Newswire via SeaPRwire.com) - Sharp Corporation (hereinafter "Sharp") has established an official partnership with Tottenham Hotspur FC (hereinafter "Spurs"), a professional football club in the English Premier League, for their Pre-season Tour 2025. This partnership will be effective from July 1, 2025 to September 30, 2025, under the AQUOS brand representing Sharp's smartphones and TVs.Sharp is engaged in the development of smartphones and televisions AQUOS, delivering high-definition images that provide an immersive experience. By leveraging cutting-edge technology, Sharp strives to create innovative products. This resonates with the Spurs' spirit of "TO DARE IS TO DO", leading to establishment of this partnership with AQUOS. Through this partnership, Sharp will support Spurs in their endeavors.Additionally, a variety of promotional activities will be implemented in Japan, Taiwan, Singapore, and Indonesia, where the smartphones AQUOS is available. These include video content featuring the players, showcasing the appeal of the smartphones AQUOS. Further details will be shared through the official social media channels of AQUOS in each country and region (details to follow).Contract TitleBrandRegionsPartnership DurationTottenham Hotspur FCPre-season Tour 2025 Official PartnershipAQUOSJapan, Taiwan, Singapore, IndonesiaFrom July 1, 2025 to September 30, 2025 About Tottenham Hotspur FCTottenham Hotspur FC (commonly known as Spurs) is a professional football club based in North London and competes in the English Premier League. Since its establishment in 1882, the club has won numerous titles – including the 2025 UEFA Europa League. The club's motto, "TO DARE IS TO DO", embodies its commitment to pursuing innovative play and embracing challenges. Spurs also have deep roots in the community and actively engage in social contribution initiatives.Official Social Media for Smartphones AQUOSFurther details will be announced sequentially through the following social media accounts.RegionsType of Social MediaJapanInstagram@aquosmobile_officialhttps://www.instagram.com/aquosmobile_official/YouTube@aquosphonesharphttps://www.youtube.com/user/AQUOSPHONESharpTaiwanFacebookhttps://www.facebook.com/SharpMobileTW/Instagram@sharpmobiletwhttps://www.instagram.com/sharpmobiletw/SingaporeFacebookhttps://www.facebook.com/sharpsingaporeInstagram@sharp_singaporehttps://www.instagram.com/sharp_singapore/IndonesiaFacebookhttps://www.facebook.com/sharpindonesiaInstagram@sharpindonesiahttps://www.instagram.com/sharpindonesia/AQUOS and the AQUOS logo are trademarks or registered trademarks of Sharp Corporation. Copyright 2025 JCN Newswire via SeaPRwire.com.

11 7 月, 2025

Hitachi develops “Metaverse Platform for Nuclear Power Plants” to enhance efficiency in construction and maintenance operations

Combined Hitachi Group's expertise in the nuclear energy business with its digital technologies to develop a platform utilizing a metaverse and AI solution.Streamlines operations from design, on-site construction and maintenance to asset management by enabling the sharing of site conditions with electric utilities and partners such as constructors through a high-precision digital twin of nuclear facilities in a metaverse.Image of virtual spaces recreated on-site and related functions in the Metaverse Platform for Nuclear Power PlantsTOKYO, July 9, 2025 - (JCN Newswire via SeaPRwire.com) - Hitachi, Ltd. (TSE:6501, "Hitachi"), announced today the development of a new “Metaverse Platform for Nuclear Power Plants” that leverages a metaverse and AI technology to streamline operations, including nuclear power plants' safety enhancement, new plant construction, maintenance, and decommissioning. The platform recreates nuclear power plants in a metaverse using high-precision point cloud data and 3D CAD data, and aims to enhance productivity in information sharing, schedule coordination, and asset management among stakeholders by utilizing it with partners such as electric utilities and contractors.It is also designed to serve as the foundation of a “Data-Driven Power Plant,” which we aim to establish to address the diverse needs and challenges faced by electric utilities–such as improving equipment reliability, enhancing work management, and increasing operational efficiency–through data-driven value creation and problem-solving. This new platform embodies Lumada 3.0, which uses Hitachi's domain knowledge and AI to convert data into value to solve challenges faced by customers and society, and was developed together with GlobalLogic as One Hitachi, integrating Hitachi's decades-long expertise in the nuclear energy business with its Group-wide advanced digital technologies. The platform facilitates the collection, aggregation, and analysis of on-site data, thereby supporting optimal investment planning and plant maintenance through data-driven insights.BackgroundIn the installation of new equipment or modification in nuclear power plants, precise planning and reliable execution are essential to complete on-site work within the shortest possible timeframe. However, access to nuclear power plants is often restricted by regulations, limiting the frequency and duration of site surveys. In some cases, controlled zones are not accessible during operation, restricting on-site surveys. These constraints require extensive coordination among stakeholders, with electric utilities playing a central role in sharing information and revising work plans.Moreover, following the Great East Japan Earthquake, all domestic nuclear power plants were shut down for extended periods. During this time, the industry experienced a wave of retirements among highly skilled and knowledgeable personnel, a decline in on-site training opportunities for new plant construction, and a shrinking labor force due to demographic changes such as an aging population and declining birthrate. These factors have made knowledge transfer and productivity enhancement pressing challenges across the nuclear sector.In response, Hitachi has developed the Metaverse Platform for Nuclear Power Plants to further enhance productivity by enabling accurate understanding and seamless sharing of site conditions among stakeholders, real-time schedule coordination, and reduction of rework.Key Features of the Metaverse Platform of Nuclear Power Plants1. Point Cloud Data & CAD alignmentOverlays high-precision, high-density point cloud data*1 and 3D CAD*2 models to recreate nuclear power plants in a metaverse. This enables precise verification of site conditions and identification of discrepancies between drawings and actual structures.2. AI SearchIncorporates natural language processing to allow full-text and synonym-based searches of design documentation. Location and equipment-specific data in the metaverse enhances search accuracy.3. Multi-User CollaborationSupports simultaneous access to the metaverse by multiple users, facilitating real-time communication and decision-making across geographically dispersed stakeholders.4. Engineering Support ToolsOffers centimeter-level measurement capabilities, virtual meetings, annotation, file attachment to specific equipment or areas, equipment layout search, and asset information linking functions to assist engineering operations.5. SecurityEnsures secure communication through encrypted interactions in the metaverse and access control limited to authorized users.*1 A dense collection of spatial points captured by 3D scanners or cameras, used to represent the shape of objects or environments in three dimensions.*2 Computer Aided Design software used for creating and editing engineering drawings and models digitally.Future Applications and VisionThe Metaverse Platform for Nuclear Power Plants is designed to serve as the foundation for a “Data-Driven Power Plant”, enabling the collection, aggregation, and analysis of on-site data such as equipment conditions. This will facilitate optimal investment and maintenance planning by detecting failures in advance and predicting future equipment conditions, thereby realizing data-driven decision-making. This enables Hitachi to address the diverse needs and challenges faced by electric utilities–such as improving equipment reliability, enhancing work management, and increasing operational efficiency–through data-driven value creation and problem-solving.Conceptual image of a data-driven power plantWebsite of the Metaverse Platform for Nuclear Power Plantshttps://www.hitachi.com/products/energy/nuclear/digital_ai/nuclear_metaverse/index.htmlIntroduction at Hitachi Social Innovation Forum 2025 JAPAN, OSAKAThe Metaverse Platform of Nuclear Power Plants will be showcased at "Hitachi Social Innovation Forum 2025 JAPAN, OSAKA" held on July 17th (Thu). Learn more about the service at " BS01-03: Integrating Energy and Digital Technology for a Sustainable Future" (July 17th 11:50~12:40) and the exhibition “EX01-04: Next-Generation Workstyles in the Nuclear Industry Using Hitachi's Metaverse.”For more information on "Hitachi Social Innovation Forum 2025 JAPAN, OSAKA", please visit the official website at: https://www.service.event.hitachi/en/regist/About LumadaIn order to read a PDF file, you need to have Adobe Acrobat Reader installed in your computer.About Hitachi, Ltd.Through its Social Innovation Business (SIB) that brings together IT, OT(Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com. Copyright 2025 JCN Newswire via SeaPRwire.com.

11 7 月, 2025

康诺思腾自主创新研发的手术机器人 成功于英国启动首轮临床试验

香港,2025年7月9日 - (亚太商讯 via SeaPRwire.com) - 中国创新型手术机器人企业代表康诺思腾(Cornerstone Robotics)欣然宣布,由其自主研发的手术机器人系统Sentire思腾®腔镜手术机器人(C1000)正式于英国朴茨茅斯大学医院国民保健信托(Portsmouth Hospitals University NHS Trust)("PHU")旗下的亚历山德拉皇后医院启动首轮临床试验。这项极具开创性的项目,见证着Sentire思腾®腔镜手术机器人首次在英国及欧洲展开临床应用,是国际临床合作上的重大里程碑,也为康诺思腾在该地区的商业发展拉开了序幕。近期,PHU外科团队在Jim Khan教授的带领下,成功以Sentire思腾®腔镜手术机器人完成三例结直肠手术,标志着本次临床试验的成功启动。基于早前于亚洲地区获得的临床数据,本次于英国进行的临床试验旨在进一步评估应用Sentire思腾®腔镜手术机器人为欧洲群体进行结直肠及泌尿外科手术的安全性和有效性。该试验遵循国际医疗器械评估标准,标志着中国手术机器人在国际临床的监管审批与临床应用上开创出双重突破。PHU外科团队首席研究员Jim Khan教授表示:"Sentire思腾®腔镜手术机器人在临床操作中展现出卓越的稳定性与易用性,团队因此能迅速掌握,其操作流程的表现令人印象深刻。我衷心感谢康诺思腾团队在此开创性阶段提供的专业支援。"康诺思腾首席执行官欧国威教授表示:"此次临床评估是公司发展的重要里程碑,也标志着香港创新生态体系的一次突破性成就。我们很荣幸能与PHU合作并在英国启动这项全球首创的临床研究。我们相信,该项研究结果将有力验证Sentire思腾®腔镜手术机器人的临床价值,为英国、欧盟等地区提供更高效、更普惠的手术机器人解决方案。"Sentire思腾®腔镜手术机器人将临床应用技术与集成工程、软件及成像技术相结合,旨在辅助外科医生执行复杂的微创手术。早期临床评估反馈显示,这些特性有助于优化手术团队的工作流程,并改善患者的预后情况。此次合作亦巩固了PHU在手术机器人领域的前沿地位。PHU作为英国首个专注运营机器人辅助日间手术项目的机构,在结直肠外科、泌尿外科、上消化道外科及妇科领域完成了逾5,000例机器人手术 - 为英国国民保健署(NHS)采用先进手术技术提供了可推广的示范案例。关于朴茨茅斯大学医院国民保健信托(PHU)朴茨茅斯大学医院国民保健信托(PHU)位于英国亚历山德拉皇后医院,为汉普郡逾67.5万人口提供急症诊疗服务。2000年代初,PHU便开始引领微创手术发展,目前在手术机器人领域已是国际公认的主导者。自2012年引入手术机器人技术至今,PHU已在结直肠外科、泌尿外科、上消化道外科及妇科等领域完成逾5,000例机器人手术,为英国国民保健体系(NHS)重塑外科诊疗标准树立典范。此外,PHU亦率先在英国推行机器人辅助日间手术项目,并持续引领临床机器人研究创新。关于康诺思腾(Cornerstone Robotics)康诺思腾(Cornerstone Robotics)是中国创新型手术机器人的引领者,怀着"引领医疗创新,心系天下健康"的愿景,致力于打造安全高效的手术机器人平台,提升中国乃至全球范围优质医疗资源的可及性,让更多患者受益于高端医疗科技带来的高品质医疗服务。公司已在全球设立四大研发中心,并在中国香港、深圳、北京、上海和美国波士顿、荷兰阿姆斯特丹、英国朴次茅斯设有分支机构,在粤港澳大湾区建成超万平米的量产工厂。凭借雄厚的技术实力,公司已成功攻克技术难题,搭建起全面底层技术平台,由康诺思腾自主研发的Sentire思腾®腔镜手术机器人已完成多个重要专科的临床试验,并正式获得国家药品监督管理局(NMPA)批准上市,同步在全球范围申请医疗器械认证,服务全球医护,惠及更多病患。 Copyright 2025 亚太商讯 via SeaPRwire.com.

10 7 月, 2025

港股最大机器人IPO!国配认购超30倍 极智嘉正式在香港交易所主板挂牌上市

香港,2025年7月9日 - (亚太商讯 via SeaPRwire.com) - 在全球供应链重塑与物流自动化持续升级的大背景下,自主移动机器人(AMR)正快速取代传统仓储方式,成为支撑智能制造和智能零售的重要底座。在全球仓储AMR行业中,北京极智嘉科技股份有限公司(「极智嘉」)是当之无愧的行业龙头,连续六年全球仓储履约AMR机器人市场份额第一。7月9日,极智嘉以股份代号2590登陆联交所主板,不仅是年内港股最大规模的机器人企业IPO,更是全球AMR仓储机器人第一股。极智嘉今日开盘一度报于每股17.00港元,市值超220亿港元。此次发行受到市场热捧,香港公开发售超额认购133.62倍,国际配售获30.17倍认购,是今年港股最高倍数的国际配售Top 3,更创下港股科技板块最高国际配售倍数纪录。主权财富基金、大量国际长线基金、科技专项基金以及对冲基金踊跃认购。基石投资者阵容汇聚国际资本巨头、顶级风投、国资力量与产业龙头,彰显资本市场对于机器人赛道的战略共识,以及对极智嘉商业化能力和技术价值的认可。作为一家稀缺的商业化成功机器人企业,极智嘉港股上市为投资者打开一个切入千亿级产业增量的绝佳窗口。赛道空间明确,稳居全球第一高地作为仓储自动化的主要驱动力, AMR解决方案以其灵活性及效率正在对行业进行改革。根据灼识咨询资料,预计到2029年,全球AMR解决方案市场规模将达到人民币1,621亿元,2024年至2029年的复合年增长率为33.1%。AMR解决方案在整体仓储自动化领域的渗透率预计从2024年的8.2%,上升至2029年的20.2%,使AMR解决方案成为仓储自动化中不可或缺的力量。在这一极具成长潜力的市场,极智嘉已占据全球第一高位,是少数能在高端欧美市场占据领导地位的中国科技公司。根据灼识咨询的资料,按收入计,极智嘉是全球最大的仓储履约AMR解决方案提供商,连续 6 年蝉联第一。截至2024年底,极智嘉已向全球40多个国家和地区交付了约56,000台AMR,累计部署超 1,500个全球项目,产品矩阵涵盖货架到人、货箱到人、托盘到人、分拣、搬运等多个成熟应用场景。同时,极智嘉也是一家真正实现全球化成功的中国机器人企业。为了支撑全球交付,极智嘉在全球范围内建立了48个服务站和13个备件中心,超300名工程技术人员,实现7×24小时运维响应,实现全球交付与本地化服务能力,从而在欧美等国际市场快速取得成功,深受全球客户信赖,其中不乏UPS等行业巨头。截至2024年底,极智嘉在全球AMR市场拥有最广泛的全球业务。2024年,公司中国大陆以外市场AMR收入达人民币17.4亿元,收入占比达72.1%,已成为公司的第一大收入增长引擎。收入高速增长,盈利质量持续优化伴随着商业化的全球推进,极智嘉迎来收入的高速增长。2024年,极智嘉收入达24.09亿元人民币,2021-2024年复合年增长率高达45.1%。, 2024年,极智嘉经调整EBITDA大幅收窄至-0.25亿元,经调整净亏损率降至3.8%,盈利质量持续改善,盈亏平衡临近。据统计,在港股机器人企业中,极智嘉2024年营收规模高于其他港股ToB机器人企业,凭借"高规模、高增长、低亏损"的财务亮点,成为少数具备明确商业化模型与兑现路径的机器人企业之一。图: 港股ToB机器人企业2024年业绩汇总 (按收入规模排序)同时,极智嘉毛利率保持高位稳定,毛利持续上升。2024年,公司整体毛利率为34.8%,2021-2024年公司整体毛利复合年增长率118.5%。值得一提的是,极智嘉海外毛利率较高,2024年大陆以外市场AMR毛利率46.5%,高于整体毛利率水平。未来,随着海外收入占比的持续提升,公司整体盈利能力有望进一步增强,推动其加速走向盈利。业绩的高速增长离不开客户经营战略的成功。截至2024年底,极智嘉累计服务超800 家终端客户,其中包括超 60 家全球财富500强客户,拥有全球最大客户基础。不仅如此,广泛的解决方案创造追加销售和交叉销售机会,进一步提升客户粘性。2024年,极智嘉关键终端客户复购率达到约84.3%,远超行业平均水平。整体客户回复购率达到74.6%,体现出极强的了客户黏性及忠诚度。同期,极智嘉新签订单总额达31.4亿元,为后续业绩增长提供充足保障。技术实力奠定发展基础 上市助力释放长期增长潜力极智嘉的成功,建立在深厚的技术实力之上。公司已构建全球领先的通用机器人平台,协同所有软硬件模块,具备多机器人协同调度与灵活部署能力。其自研的大规模多机混合调度系统,支持单仓超5000台设备并行协同作业,并在全球拥有多个"千台级"案例落地,超越行业平均水平。公开数据显示,早在 2023年初,Bloomberg曾报导韩国电商巨头Coupang与极智嘉共同打造千台级机器人仓,让仓库运营效率获得提升。3PL 巨头 UPS也已实践千台规模智能仓,充分验证了极智嘉的调度能力。据统计,极智嘉曾四次荣登RBR50全球机器人Top50创新榜单,强大技术实力备受国际权威认可。本次港股上市,极智嘉计划将募集资金主要用于持续投入研发和产品迭代、扩大销售及服务网络,提升全球品牌影响力、支持供应链发展,提升全球化交付效率与成本控制能力等,此将进一步强化其全球市场竞争力,加速其全球市场渗透。作为全球AMR市场中,商业化最成功的公司之一,极智嘉代表了中国科技企业在智能制造领域的超强实力与国际竞争力,在港股市场极具稀缺性。在AMR赛道进入产业红利释放期之际,极智嘉凭借全球落地能力、技术平台实力与强韧的财务结构,有望引领下一轮智能制造周期,实现长期价值的持续释放。 Copyright 2025 亚太商讯 via SeaPRwire.com.

10 7 月, 2025

“Development of Integrated Simulation Platform for Sustainable and Competitive Maritime Industry” has been selected as a R&D project under K Program

TOKYO, July 8, 2025 - (JCN Newswire via SeaPRwire.com) - MTI Co., Ltd. (a NYK Group company), Mitsubishi Shipbuilding Co., Ltd., TSUNEISHI SHIPBUILDING Co., Ltd., Japan Agency for Marine-Earth Science and Technology, Japan Marine United Corporation, Mitsui E&S Co., Ltd., National Maritime Research Institute, TSUNEISHI AKISHIMA LABORATORY Co., Ltd. (formerly Akishima Laboratory Inc.), Graduate School of Engineering The University of Osaka and Kyoto University cooperatively proposed a project "Development of Integrated Simulation Platform for Sustainable and Competitive Maritime Industry" and the project has been selected by JST, Japan Science and Technology Agency. It aims at to realize the R&D Concept of "High-Performance Next-Generation Vessel Development Technology Using Digital Technology and High-Resolution and High-Precision Environmental Change Prediction Technologies to Support the Stable Operation of Vessels (Tentative Translation)" set out in the Key and Advanced Technology R&D through Cross Community Collaboration Program (K Program) of Japanese Government.K Program promotes research and development, as well as the utilization of its outcomes, for advanced and critical technologies that are essential for Japan to maintain a solid position in the international community over the medium to long term. As one of the projects undertaken in the K Program, we aim to secure world-leading next generation ship development, design and construction capabilities, and ensuring safe marine transportation in accordance with the R&D vision identified by Integrated Innovation Strategy Promotion Council and the R&D Concept set out by Japan's Cabinet Office and MEXT, Ministry of Education, Culture, Sports, Science and Technology.1.Project Title:"Development of Integrated Simulation Platform for Sustainable and Competitive Maritime Industry"*The project title could be changed at a later stage2.Project Leader:Hideyuki ANDO, Director of MTI Co., Ltd.3.Project outline:The focus of ship demand will shift toward high-performance next-generation ships that adopt alternative fuels to reduce greenhouse gas emissions, energy-saving technologies such as wind propulsion, and advanced integrated control systems including autonomous navigation. Japan's maritime industry faces the challenge of developing and supplying next-generation ships with increasingly sophisticated and complex functions in shorter lead time, while also expanding its shipbuilding capacity to meet growing global demand amid a declining labor force. To address this, this research and development project will establish an "Integrated Simulation Platform" that enables simultaneous consideration of ship lifecycle and supply chain, at the initial development and design stages, to optimize ship design and construction plans. This project will promote the implementation of virtual engineering concept and techniques into the maritime industry. Additionally, regarding weather and sea condition predictions that impact the safe and stable ship operations, a seasonal prediction technology, covering 1 to 3 months in advance, including extreme phenomena such as typhoons, will be developed and integrated into the platform.4.Project period: 5 years*The project will start after the Program Director approves the project plan.5.Project budget: Maximum JPY 12 billion*The total budget in the entire R&D Concept6.Contact information:MTI Co., Ltd.JCAST Project Management Office under K ProgramE-mail: MTI.ML.JCAST_Admin@monohakobi.com7.Related links:i.JST Press Releases (in Japanese)https://www.jst.go.jp/pr/info/info1772/index.htmlii.Japan's Cabinet Office: R&D Concept (in Japanese)"High-Performance Next-Generation Vessel Development Technology Using Digital Technology and High-Resolution and High-Precision Environmental Change Prediction Technologies to Support the Stable Operation of Vessels (Tentative Translation)"https://www8.cao.go.jp/cstp/anzen_anshin/2_20231225_mext.pdfAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2025 JCN Newswire via SeaPRwire.com.

9 7 月, 2025

翼菲科技冲刺港股:轻工业机器人先锋 全栈技术驱动商业化潜力可期

香港,2025年7月8日 - (亚太商讯 via SeaPRwire.com) - 作为人工智能与实体经济深度融合的重要领域,机器人因其丰富的应用场景与技术发展潜力,正成为资本竞逐的新高地。今年以来,港股机器人板块表现亮眼,吸引众多机器人企业竞相登陆资本市场,市场热度持续攀升。6月30日,机器人行业又一新锐玩家浙江翼菲智能科技股份有限公司("翼菲科技")向港交所递交上市申请,拟乘行业东风与资本红利,开启高质量增长新阶段。全栈技术赋能,定义轻工业机器人新高度翼菲科技的核心竞争力源于其自建的、覆盖机器人核心模块的全栈技术体系。公司创新性地模拟熟练技术工人的作业逻辑,打造出集"脑"(智能决策与精确控制)、"眼"(智能感知与动态追踪)、"手"(高速灵巧与工业精度)、"足"(精确导航与自主避障)四大支柱的完整技术架构,实现四大功能模块从感知到执行的毫秒级协调,显著提升机器人在复杂场景下的运行效率和柔性适应能力。在这一技术框架的支持下,翼菲科技推出覆盖多个应用维度的机器人产品组合,包括并联机器人(Bat系列)、AGV/AMR移动机器人(Camel系列)、SCARA机器人(Python系列)、晶圆搬运机器人(Lobster系列)及六轴工业机器人(Mantis系列),与自主开发的控制系统与视觉系统协同运作,可有效满足轻工业对高速、高精度的核心需求,构筑了难以复制的竞争护城河。目前,翼菲科技机器人产品已服务超过千个具体应用场景,广泛覆盖消费电子、新能源、医疗、快消、半导体等轻工业核心领域,为企业用户带来效率、成本与质量的三重跃升,赢得全球行业巨头的广泛认可,客户名单包括全球最大智能手机显示屏供应商、生物活性材料与合成生物学全球领导者、头部新能源车企及国际综合医疗系统巨头等。业绩稳健增长,全球化布局打开想象空间得益于产品组合的不断扩展、市场需求的持续增加以及客户基础的快速扩大,翼菲科技营收实现稳健增长。2022-2024年,公司营收从1.62亿元跃升至2.68亿元,复合年增长率28.5%,毛利从4325万元增至7102万元,显示出极强的商业化变现能力。从收入结构来看,海外市场收入增长动能正逐步释放。2024年,翼菲科技海外收入2550万元,收入占比9.5%。截至2024年底,翼菲科技已在7个国家建立区域代理商网络,业务版图覆盖欧美、拉美及东南亚20多个国家和地区。随着本地化服务体系的持续完善,海外业务有望为公司贡献更大业绩增量。从行业趋势看,在自动化升级及政策支持的推动下,中国轻工业机器人市场迅速扩张。根据弗若斯特沙利文预测,中国轻工业机器人市场预计至2029年将达到人民币438亿元,2025年至2029年的复合年增长率为16.3%。而中国轻工业机器人解决方案市场增速更高,预期同期复合年增长率将达到19.5%,于2029年升至1710亿元。与此同时,供应链本土化进程推动国产替代需求强劲释放,为本土头部企业带来确定性成长机遇。翼菲科技以自主可控的全栈技术体系与针对性极强的产品组合,精准卡位轻工业机器人蓝海,形成差异化竞争优势。更为关键的是,公司持续攀升的业绩表现已充分验证其技术落地能力,而头部客户背书、海外布局初具规模也为其打开更广阔的成长空间。随着国产替代趋势加速,产业智能化升级红利释放,翼菲科技有望在行业竞争中持续扩大领先身位,释放更具潜力的成长曲线。 Copyright 2025 亚太商讯 via SeaPRwire.com.

8 7 月, 2025

Eisai Selected as Supplier Engagement Leader, CDP’s Highest Rating in the Supplier Engagement Assessment

TOKYO, July 8, 2025 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced that it has been selected for the highest rating of “Supplier Engagement Leader” in the Supplier Engagement Rating by the global environmental non-profit organization CDP.(1)The Supplier Engagement Assessment evaluates how effectively companies are working with suppliers to address climate change issues. In its responses to the CDP Climate Change Questionnaire on 'Governance', 'Targets', 'Scope 3 emissions(2)' and 'Value chain engagement', Eisai’s efforts to engage with suppliers were highly regarded, leading to this selection. To conduct environmentally conscious business activities throughout our entire supply chain, Eisai asks business partners to comply with the “Eisai Global Code of Conduct for Business Partners(3)” which clearly states Eisai’s requirement for environmental conservation. Collaboration with suppliers is also strengthened by conducting sustainability assessments of partners and providing feedback on the results.Eisai identifies “Business activities with consideration for the global environment” as one of its material issues. Based on the “Eisai Network Companies Environmental Protection Policy”, Eisai is promoting responses to climate change as key environmental activities across the group. Eisai is working towards the realization of a decarbonized society, including receiving approval for the SBT 1.5°C target from the Science Based Targets (SBT) Initiative in FY2023, and participating in the Japan Climate Initiative (JCI)Race to Zero Circle, which calls for achieving net zero by 2050.(4)Please refer to Eisai’s website for more detailed information about its environmental activities.The preservation of the global environment is essential for realizing Eisai’s corporate concept of human health care (hhc). Eisai will contribute to empowering people to “realize their fullest lives” through our climate change initiatives.(1)A non-profit organization headquartered in the UK. The organization operates the world’s only independent environmental information disclosure system.(2)Indirect greenhouse gas emissions across the entire corporate value chain(3)Please refer here for further details(4)Please refer to the following news release for details. EISAI TO BOOST INITIATIVES ON GREENHOUSE GASREDUCTION, AIMING TO ACHIEVE NET ZERO BY 2050https:/www.eisai.com/news/2024/news202412.htmlMedia Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120  Copyright 2025 JCN Newswire via SeaPRwire.com.

8 7 月, 2025